James Hamilton

Arrowhead Pharmaceuticals (United States)

Also affiliated with Madison Group (United States)

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease”.

Development of an RNAi therapeutic for alpha-1-antitrypsin liver disease

JCI Insight(2020)10.1172/jci.insight.135348

N/A

0DataRank · unranked

59 citations

Keith Blomenkamp, Ryan M. Peterson, Владимир Субботин, Christian Schwabe, James Hamilton +12 more

Role of angiopoietin-like protein 3 in sugar-induced dyslipidemia in rhesus macaques: suppression by fish oil or RNAi

Journal of Lipid Research(2020)10.1194/jlr.ra119000423

N/A

0DataRank · unranked

18 citations

James L. Graham, Kimber L. Stanhope, So C. Wong, Sarah M. King, Andrew A. Bremer +4 more